Development of DYRK1A allosteric modulator for the treatment of alzheimer?s disease
Ended Project Grant Awarded Last action
- Award ID
- R44AG056181
- Recipient
-
Avanti Biosciences, Inc. UEI GZNJSM9ELXB3
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,279,661
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$61 | |
| Amendment | -$61 | |
| Amendment | $375,862 | |
| Amendment | $350,000 | |
| Amendment | $971,320 | |
| Amendment | -$1,096 | |
| Amendment | $1,096 | |
| Amendment | $0 | |
| Original award | $582,601 |
Quick answers
Who received award R44AG056181?
R44AG056181 was awarded to Avanti Biosciences, Inc. by National Institute on Aging (National Institutes of Health) on August 15, 2017.
How much is award R44AG056181 worth?
$2,279,661 has been obligated on R44AG056181.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award